Nutrien Q3 Earnings Fall 39%, Retail Guidance Cut, White Springs Phosphate Mine to Shut
NTR sits 35% above its 52-week low of $53.03.
Summary
Nutrien reported Q3 net earnings of $288 million ($0.60 per share), down 39% year over year, cut Retail EBITDA guidance, and said it will shut its White Springs phosphate mine in Q2 2027 with $430 million of assets facing impairment.
Key Events · Earnings and Guidance · NTR
-
Q3 Earnings Drop 39%
Net earnings fell to $288 million ($0.60 diluted EPS) from $469 million, and adjusted EBITDA declined 8% to $1.31 billion, with phosphate posting a $50 million gross margin loss.
-
Retail Guidance Cut
Full-year Retail adjusted EBITDA guidance was lowered to $1.72-$1.85 billion from $1.75-$1.95 billion on weaker crop nutrient margins; potash volumes were raised to 14.3-14.8 Mt and capex trimmed to $1.95-$2.00 billion.
-
White Springs Mine to Close
The phosphate strategic review ends with Aurora retained and White Springs shut in Q2 2027; $430 million of assets will be assessed for impairment, and the closure is expected to cut annual sustaining capex and lease payments by about $50 million.
-
Q4 Impairment Charges Loom
Alongside the previously announced Trinidad nitrogen shutdown ($760 million of assets to be tested), Nutrien expects non-cash asset and goodwill impairments plus severance in Q4 2026.
Analysis · NTR · Industrial Applications And Services
Nutrien's third-quarter net earnings fell to $288 million ($0.60 per diluted share) from $469 million a year earlier, while adjusted EBITDA slipped 8% to $1.31 billion. The phosphate segment swung to a $50 million gross margin loss on higher sulfur costs and weaker nitrogen volumes. Management cut full-year Retail adjusted EBITDA guidance to $1.72-$1.85 billion from $1.75-$1.95 billion, but raised potash and nitrogen volume targets and lowered capital spending to $1.95-$2.00 billion. The bigger strategic news is the conclusion of the phosphate review: Nutrien keeps Aurora but will shut the White Springs mine in Q2 2027, with $430 million of assets flagged for impairment and roughly $50 million of annual sustaining capex and lease savings. Combined with the previously announced Trinidad nitrogen shutdown ($760 million of assets to be tested for impairment), the company is taking real write-downs in Q4 while shrinking its cost base.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NTR was trading at $71.60 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $34.3B. The 52-week trading range was $53.03 to $85.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.